Notice of Effectiveness

Climb Bio, Inc. Filed 2024-07-23 Acc 9999999995-24-002249

Documents 1

2024-11-22 EFFECT Notice of Effectiveness
2024-07-23 EFFECT Notice of Effectiveness
2024-07-23 4 EVP, R&D AND CSO sold 129,206 shares at an average $7.65 ($988,495)
2024-07-23 424B3 Prospectus
2024-07-19 4 EVP, R&D AND CSO sold 41,783 shares at an average $6.93 ($289,492)
2024-07-19 CORRESP Correspondence Between Filers and SEC Staff
2021-08-09 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…